Cellromax Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Apr '26 Apr 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	58,075	73,574	57,231
Market Cap Growth	11.20%	28.56%	-
Enterprise Value	50,849	68,367	-
Last Close Price	5260.00	6500.00	4751.76
PE Ratio	20.15	24.80	14.99
PS Ratio	2.62	3.32	2.65
PB Ratio	1.24	1.57	1.29
P/TBV Ratio	1.32	1.67	1.39
P/FCF Ratio	34.03	43.11	9.40
P/OCF Ratio	32.53	41.21	9.09
EV/Sales Ratio	2.29	3.08	-
EV/EBITDA Ratio	15.34	20.63	-
EV/EBIT Ratio	17.93	24.11	-
EV/FCF Ratio	29.79	40.06	-
Debt / Equity Ratio	0.01	0.01	0.03
Debt / EBITDA Ratio	0.14	0.14	0.25
Debt / FCF Ratio	0.28	0.28	0.25
Net Debt / Equity Ratio	-0.15	-0.15	-0.48
Net Debt / EBITDA Ratio	-2.18	-2.18	-3.58
Net Debt / FCF Ratio	-4.23	-4.23	-3.49
Asset Turnover	0.44	0.44	-
Inventory Turnover	2.14	2.14	-
Quick Ratio	3.08	3.08	7.41
Current Ratio	5.20	5.20	9.10
Return on Equity (ROE)	6.49%	6.49%	-
Return on Assets (ROA)	3.54%	3.54%	-
Return on Invested Capital (ROIC)	6.27%	7.74%	17.55%
Return on Capital Employed (ROCE)	5.90%	5.90%	12.00%
Earnings Yield	5.11%	4.03%	6.67%
FCF Yield	2.94%	2.32%	10.64%
Payout Ratio	114.25%	114.25%	-
Buyback Yield / Dilution	-9.27%	-9.27%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.